SMARTSET GHV GENTAMICIN 40G
Report
- Report Number
- 1818910-2019-110332
- Event Type
- Injury
- Date Received
- October 17, 2019
- Date of Event
- December 4, 2018
- Report Date
- September 24, 2019
- Manufacturer
- DEPUY CMW - 9610921
- Product Code
- LOD
- UDI-DI
- 10603295174288
- PMA / PMN Number
- K033563
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER
Narratives
PRODUCT COMPLAINT # (B)(4). MFR#1818910-2019-110332 IS BEING RETRACTED SINCE IT WAS FOUND TO BE A DUPLICATE OF MFR# 1818910-2019-79537. MFR#1818910-2019-79537 WILL BE KEPT FOR INVESTIGATION PURPOSES
(B)(4). INITIAL REPORTER OCCUPATION: LAWYER. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.
MEDICAL RECORDS RECEIVED 17 JUNE 2019 AND WERE REVIEWED 24 SEPTEMBER 2019 FOR MDR REPORTABILITY. ON (B)(6) 2014, THE PATIENT UNDERWENT TOTAL RIGHT KNEE ARTHROPLASTY DUE TO OSTEOARTHRITIS. THE PATELLA WAS RESURFACED. THE SURGEON REPORTED NO INTRAOPERATIVE COMPLICATIONS. THE PATIENT WAS IMPLANTED WITH THE ATTUNE KNEE SYSTEM AND SMARTSET BONE CEMENT X 2. ON (B)(6) 2018, THE PATIENT UNDERWENT A RIGHT KNEE REVISION DUE TO LOOSENING OF THE TIBIAL COMPONENT, AND PAIN. THE SURGEON INDICATED THE TIBIAL COMPONENT WAS LOOSE WITH NO CEMENT ADHERING TO THE IMPLANT. HE NOTED THE FEMORAL COMPONENT WAS NOT LOOSE AND WAS NOT REVISED. THE SURGEON INDICATED THE PATELLAR COMPONENT WAS STABLE AND NOT REVISED. THE PATIENT WAS IMPLANTED WITH A COMPETITOR¿S TIBIAL COMPONENTS AND CEMENT. THERE WERE NO COMPLICATIONS TO THE PROCEDURE. DOI: (B)(6) 2014; DOR: (B)(6) 2018; (RT KNEE).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 996675 | SMARTSET GHV GENTAMICIN 40G | BONE CEMENT : BONE CEMENT | LOD | DEPUY CMW - 9610921 | 7786750 | 10603295174288 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Required Intervention |